JP2006232807A - Antioxidant containing horseradish extract - Google Patents
Antioxidant containing horseradish extract Download PDFInfo
- Publication number
- JP2006232807A JP2006232807A JP2005268402A JP2005268402A JP2006232807A JP 2006232807 A JP2006232807 A JP 2006232807A JP 2005268402 A JP2005268402 A JP 2005268402A JP 2005268402 A JP2005268402 A JP 2005268402A JP 2006232807 A JP2006232807 A JP 2006232807A
- Authority
- JP
- Japan
- Prior art keywords
- horseradish
- extract
- antioxidant
- ascorbic acid
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 73
- 240000003291 Armoracia rusticana Species 0.000 title claims abstract description 71
- 235000011330 Armoracia rusticana Nutrition 0.000 title claims abstract description 70
- 239000000284 extract Substances 0.000 title claims abstract description 66
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 62
- 235000006708 antioxidants Nutrition 0.000 claims description 57
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 22
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 21
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 20
- 235000013824 polyphenols Nutrition 0.000 claims description 20
- 239000004480 active ingredient Substances 0.000 claims description 16
- 229960005070 ascorbic acid Drugs 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 229960000271 arbutin Drugs 0.000 claims description 9
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 9
- 235000010323 ascorbic acid Nutrition 0.000 claims description 7
- 239000011668 ascorbic acid Substances 0.000 claims description 6
- 230000009471 action Effects 0.000 claims description 5
- 150000000996 L-ascorbic acids Chemical class 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 abstract description 10
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 4
- 239000005445 natural material Substances 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- 230000000694 effects Effects 0.000 description 22
- 238000002360 preparation method Methods 0.000 description 21
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 102000003425 Tyrosinase Human genes 0.000 description 17
- 108060008724 Tyrosinase Proteins 0.000 description 17
- 235000013305 food Nutrition 0.000 description 16
- 230000008099 melanin synthesis Effects 0.000 description 15
- 239000003814 drug Substances 0.000 description 14
- 230000002401 inhibitory effect Effects 0.000 description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 238000000605 extraction Methods 0.000 description 12
- 230000005764 inhibitory process Effects 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- -1 ethanol Chemical compound 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 239000003642 reactive oxygen metabolite Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 239000008273 gelatin Substances 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 235000011852 gelatine desserts Nutrition 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 230000002000 scavenging effect Effects 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000002087 whitening effect Effects 0.000 description 6
- 239000002028 Biomass Substances 0.000 description 5
- 239000002211 L-ascorbic acid Substances 0.000 description 5
- 235000000069 L-ascorbic acid Nutrition 0.000 description 5
- 102000019197 Superoxide Dismutase Human genes 0.000 description 5
- 108010012715 Superoxide dismutase Proteins 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 210000002752 melanocyte Anatomy 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 230000003405 preventing effect Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 239000001856 Ethyl cellulose Substances 0.000 description 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 239000003905 agrochemical Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 235000019325 ethyl cellulose Nutrition 0.000 description 3
- 229920001249 ethyl cellulose Polymers 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 210000004694 pigment cell Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000000270 basal cell Anatomy 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- QNVRIHYSUZMSGM-UHFFFAOYSA-N hexan-2-ol Chemical compound CCCCC(C)O QNVRIHYSUZMSGM-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 210000002780 melanosome Anatomy 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 238000010525 oxidative degradation reaction Methods 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- AFQOCSDOKGNDNA-OBEHBXMUSA-N (2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one (Z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCC\C=C/CCCCCCCC(O)=O AFQOCSDOKGNDNA-OBEHBXMUSA-N 0.000 description 1
- IRVNEGRHQKGRGD-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O IRVNEGRHQKGRGD-WPXUHFOISA-N 0.000 description 1
- PBTPTBMYJPCXRQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O PBTPTBMYJPCXRQ-MGMRMFRLSA-N 0.000 description 1
- MHUOEHQATDLJFZ-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;octadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O MHUOEHQATDLJFZ-WPXUHFOISA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- TZYRSLHNPKPEFV-UHFFFAOYSA-N 2-ethyl-1-butanol Chemical compound CCC(CC)CO TZYRSLHNPKPEFV-UHFFFAOYSA-N 0.000 description 1
- JYZLSYFPFQTNNO-UHFFFAOYSA-N 2-octyldecan-1-ol Chemical compound CCCCCCCCC(CO)CCCCCCCC JYZLSYFPFQTNNO-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- SGNZYJXNUURYCH-UHFFFAOYSA-N 5,6-dihydroxyindole Chemical compound C1=C(O)C(O)=CC2=C1NC=C2 SGNZYJXNUURYCH-UHFFFAOYSA-N 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 208000001382 Experimental Melanoma Diseases 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 229940119157 Hydroxy radical scavenger Drugs 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- XDBMXUKHMOFBPJ-ZAFYKAAXSA-N L-ascorbic acid 2-sulfate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OS(O)(=O)=O)=C1O XDBMXUKHMOFBPJ-ZAFYKAAXSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- TYZYAOXGQJLXLG-UCJOOIQMSA-N O=C1C(O)=C(O)[C@H](O1)[C@@H](O)CO.C(CCCCCCC\C=C/CCCCCCCC)(=O)O.C(CCCCCCC\C=C/CCCCCCCC)(=O)O.O=C1C(O)=C(O)[C@H](O1)[C@@H](O)CO Chemical compound O=C1C(O)=C(O)[C@H](O1)[C@@H](O)CO.C(CCCCCCC\C=C/CCCCCCCC)(=O)O.C(CCCCCCC\C=C/CCCCCCCC)(=O)O.O=C1C(O)=C(O)[C@H](O1)[C@@H](O)CO TYZYAOXGQJLXLG-UCJOOIQMSA-N 0.000 description 1
- YQINWFJNFJEWHH-UCLHFMLVSA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O YQINWFJNFJEWHH-UCLHFMLVSA-N 0.000 description 1
- NGUBAXUPKACQCL-UCLHFMLVSA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O NGUBAXUPKACQCL-UCLHFMLVSA-N 0.000 description 1
- QDTPSCIFGGYXJD-IPKXSQMUSA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O QDTPSCIFGGYXJD-IPKXSQMUSA-N 0.000 description 1
- GAKOHFNTEXOHTP-RXSVEWSESA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.OP(O)(=O)OP(O)(=O)OP(O)(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.OP(O)(=O)OP(O)(=O)OP(O)(O)=O GAKOHFNTEXOHTP-RXSVEWSESA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 231100000742 Plant toxin Toxicity 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 244000078534 Vaccinium myrtillus Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 244000195452 Wasabia japonica Species 0.000 description 1
- 235000000760 Wasabia japonica Nutrition 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000003655 absorption accelerator Substances 0.000 description 1
- GAMPNQJDUFQVQO-UHFFFAOYSA-N acetic acid;phthalic acid Chemical compound CC(O)=O.OC(=O)C1=CC=CC=C1C(O)=O GAMPNQJDUFQVQO-UHFFFAOYSA-N 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000008338 calamine lotion Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 150000001789 chalcones Chemical class 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 210000001787 dendrite Anatomy 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical class C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 150000002208 flavanones Chemical class 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000000497 foam cell Anatomy 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 239000008311 hydrophilic ointment Substances 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- IGGVVGHJSQSLFO-UHFFFAOYSA-N indole-5,6-quinone Chemical compound O=C1C(=O)C=C2C=CNC2=C1 IGGVVGHJSQSLFO-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 239000000712 neurohormone Substances 0.000 description 1
- 102000008434 neuropeptide hormone activity proteins Human genes 0.000 description 1
- 108040002669 neuropeptide hormone activity proteins Proteins 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical class CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 125000001474 phenylpropanoid group Chemical group 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000003123 plant toxin Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000004918 root sheath Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000010698 whale oil Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明は、抗酸化作用に優れた薬剤に関する。さらに詳しくは、西洋わさび(ワサビダイコン、Cochlearia armoracia L.)から得られる抽出物を含有する抗酸化剤に関し、抗酸化効果、特には製品の保存安定性の向上効果等の優れた酸化防止効果や、各種疾病予防効果や抗老化効果等の優れた生体内抗酸化効果を有する抗酸化剤に関するものである。 The present invention relates to a drug excellent in antioxidant action. More specifically, regarding an antioxidant containing an extract obtained from horseradish (cochlearia armoracia L.), an antioxidant effect, in particular, an excellent antioxidant effect such as an effect of improving the storage stability of the product, etc. The present invention relates to an antioxidant having excellent in vivo antioxidant effects such as various disease preventing effects and anti-aging effects.
生物は、酸素を利用することによって生存に必要なエネルギーを効率的に得ている。しかしながら、このようなエネルギー代謝のうち酸素が水に変換される過程で、中間体として活性酸素種が生じる。一般にこの活性酸素種としては、マクロファージの刺激などによって放出されるスーパーオキシド、放射線の被爆などによって生成されるヒドロキシラジカルなどが知られている。これらの活性酸素種は過度の放射線や紫外線の照射、化学物質やタバコの摂取等の外的誘因と虚血再還流、炎症、ストレス、老化等の内的要因が原因となって生成される。 Living organisms efficiently obtain energy necessary for survival by using oxygen. However, reactive oxygen species are generated as intermediates in the process of oxygen being converted to water in such energy metabolism. In general, as the reactive oxygen species, superoxide released by macrophage stimulation or the like, hydroxy radicals generated by radiation exposure, or the like are known. These reactive oxygen species are generated due to external triggers such as excessive radiation and ultraviolet radiation, intake of chemicals and tobacco, and internal factors such as ischemia reperfusion, inflammation, stress, and aging.
このようにして生体内で過剰に生成された活性酸素種は、一般に化学的反応性が高く、生体内で隣接する脂質や核酸、蛋白質等の成分と容易に反応し、さまざまな疾病に繋がる酸化的障害をもたらす。活性酸素種の一種であるスーパーオキシドは、さまざまな疾病と深い関わりがあることが明らかにされており、例えば動脈中のLDLは、スーパーオキシドによって酸化されて泡沫細胞を形成し、動脈硬化の原因を発生する。また放射線の照射によりもたらされるヒドロキシラジカルの産生は、発癌などの深刻な障害を生体に与える。(非特許文献1参照)。 In general, reactive oxygen species produced in excess in the living body are generally highly chemically reactive, and easily react with adjacent components such as lipids, nucleic acids, and proteins in the living body, leading to various diseases. Cause disability. Superoxide, a kind of reactive oxygen species, has been shown to be deeply related to various diseases. For example, LDL in arteries is oxidized by superoxide to form foam cells, causing arteriosclerosis. Is generated. Moreover, the production of hydroxy radicals brought about by irradiation of radiation gives serious damages such as carcinogenesis to the living body. (Refer nonpatent literature 1).
このような活性酸素種の生体に対する毒性が明らかになるにつれ、これらを効率的に消去する活性を有する活性酸素種消去物質等の抗酸化剤は、生体内または食品や医薬品、農薬等に含まれる成分の酸化的劣化の防御剤として有用であり、食品産業、特に水産加工品、健康食品、栄養食品のほか、医薬品・農薬分野や化粧品分野において実利的な利用が期待されているものである。 As the toxicity of such reactive oxygen species to the living body becomes clear, antioxidants such as reactive oxygen species-eliminating substances having the activity of efficiently eliminating these active oxygen species are included in the living body or in foods, pharmaceuticals, agricultural chemicals, etc. It is useful as a protective agent against oxidative degradation of ingredients, and is expected to be used practically in the food industry, in particular, processed fishery products, health foods, and nutritional foods, as well as in the pharmaceutical / agrochemical and cosmetic fields.
化粧品分野において抗酸化剤は、美白剤として利用可能である。シミ、ソバカス等皮膚への色素沈着は、紫外線を浴びることによりメラニンを合成するメラノーマ細胞内のチロシナーゼ活性が上昇し、メラニンを盛んに産生することに起因する。このメラニンは、動植物界に広く分布しているが、脊髄動物においては、メラノサイト中の細胞質顆粒メラノソームで、チロシンがチロシナーゼにより酸化されて、ドーパ、ドーパキノンが生合成され、更にドーパキノンは紫外線による自動酸化によってインドールキノン等になり、複雑な経路を経てメラニンが生合成されることが知られている(非特許文献2参照)。抗酸化剤により、チロシナーゼによる酸化反応やメラニン生合成工程における酸化反応を阻害することで、美白効果が得られることが知られている(非特許文献2参照)。 Antioxidants can be used as whitening agents in the cosmetic field. Pigmentation on the skin such as spots and buckwheat is caused by vigorous production of melanin by increasing the tyrosinase activity in melanoma cells that synthesize melanin when exposed to ultraviolet rays. This melanin is widely distributed in the animal and plant kingdoms, but in vertebrates, tyrosine is oxidized by tyrosinase in the cytoplasmic granule melanosome in melanocytes, and dopa and dopaquinone are biosynthesized. Is known to be indolequinone and the like, and melanin is biosynthesized through a complicated pathway (see Non-Patent Document 2). It is known that a whitening effect can be obtained by inhibiting an oxidation reaction by tyrosinase or an oxidation reaction in a melanin biosynthesis process with an antioxidant (see Non-Patent Document 2).
近年、抗酸化剤に限らず、化学合成品からなる食品添加物の安全性の問題に対する消費者の意識も高まっており、例えば、BHA(ブチルヒドロキシルアニソール)やBHT(ブチルヒドロキシトルエン)等の化学合成抗酸化剤は、その使用が避けられる傾向にある。また、他の抗酸化剤も、植物油由来のトコフェロール類など油溶性(非水溶性)のものが多く、実際の使用に際しては制約を受けることが多い。 In recent years, consumers have become more aware of the safety issues of food additives made of chemically synthesized products as well as antioxidants. For example, chemicals such as BHA (butylhydroxyanisole) and BHT (butylhydroxytoluene) Synthetic antioxidants tend to avoid their use. Further, many other antioxidants are oil-soluble (water-insoluble) such as vegetable oil-derived tocopherols, and are often restricted in actual use.
このような中、これまでさまざまな抗酸化剤が、主に天然物由来の原料から抽出され、その応用が検討されている。例えばスーパーオキシド消去活性を有するものとして酵素蛋白であるスーパーオキシドジスムターゼ(SOD)等が、ヒドロキシラジカル消去活性を有するものとしてマンニトール、トリプトファン、ギ酸等が挙げられている(非特許文献3)。 Under such circumstances, various antioxidants have been extracted mainly from raw materials derived from natural products, and their application has been studied. For example, superoxide dismutase (SOD), which is an enzyme protein, has superoxide scavenging activity, and mannitol, tryptophan, formic acid, and the like have hydroxyradical scavenging activity (Non-patent Document 3).
しかしながら、SODは酵素タンパクであるため、熱などに対する安定性が乏しく、また経口投与した場合、投与した酵素のほとんどは消化・排泄されてしまい、その実効力は極めて低かった。また、ヒドロキシラジカルを効率的に消去できる実用的なヒドロキシラジカル消去剤は現在のところ少ない。従って、これら抗酸化剤を工業的に多量に、かつ安定に入手することは困難なのが現状である。また、通常、前述のSODはスーパーオキシドに対してのみ消去効果を有し、ヒドロキシラジカルに対しては全く効果がない。同様にマンニトールはスーパーオキシドを消去することができない。 However, since SOD is an enzyme protein, its stability against heat and the like is poor, and when administered orally, most of the administered enzyme is digested and excreted, and its effective power is extremely low. At present, there are few practical hydroxy radical scavengers that can efficiently scavenge hydroxy radicals. Therefore, it is difficult to obtain these antioxidants industrially in large quantities and stably. In addition, the above-mentioned SOD usually has an erasing effect only on superoxide and has no effect on hydroxy radicals. Similarly, mannitol cannot eliminate superoxide.
植物からの抗酸化剤も探索されているが、不用意に植物を選択し抽出物を得ようとすると植物毒の大半をしめるアルカロイドなどが混入するおそれがある。アルカロイドは、窒素を含むアルカリ性の分子で、神経ホルモンそっくりであるため、神経線維の末端部に入り込んで神経の作用を狂わせて、毒性を発揮する。そのため、植物の選択や有効成分の抽出方法には注意が必要である。 Antioxidants from plants are also being searched for, but if an inadvertent plant is selected to obtain an extract, there is a risk of contamination with alkaloids that cause the majority of plant toxins. Alkaloid is an alkaline molecule containing nitrogen, which is similar to a neurohormone, so it enters the end of nerve fibers and defeats the action of nerves and exerts toxicity. Therefore, care must be taken in selecting plants and extracting active ingredients.
従来技術では、天然由来の抗酸化剤を工業的に多量にかつ安定に入手することは困難であり、合成品は安全面で消費者に敬遠される問題がある。従って、本発明の目的は、安全性に優れた抗酸化剤を提供することにある。 In the prior art, it is difficult to industrially obtain a large amount of natural-derived antioxidants stably, and synthetic products have a problem of being avoided by consumers in terms of safety. Accordingly, an object of the present invention is to provide an antioxidant excellent in safety.
本発明者らは、意外なことに、食品用植物である西洋わさびの抽出物が抗酸化作用を有することを見い出し、さらにかかる抽出物を有効成分として含有せしめた抗酸化剤が、例えばクリームやローション等の皮膚用外用剤として有効であることを見い出し本発明を完成したものである。 The present inventors have surprisingly found that an extract of horseradish, which is a food plant, has an antioxidant action, and further, an antioxidant containing such an extract as an active ingredient is, for example, cream or The present invention has been completed by finding that it is effective as an external preparation for skin such as lotion.
また、本発明者らは、上記有効成分を含有する西洋わさびの抽出物が、西洋わさびの根茎のみではなく、西洋わさびの葉や茎又は種々の残渣からも得られることを見い出した。西洋わさびは通常食品として根茎のみが用いられ、葉や茎はもとよりある種の酵素を抽出して得られる根茎残渣はそのまま捨てられる場合が多く、本発明を利用することにより廃材の有効利用が期待される。 In addition, the present inventors have found that an extract of horseradish containing the active ingredient can be obtained not only from the rootstock of horseradish but also from leaves and stems of horseradish or various residues. Horseradish usually uses only rhizome as a food, and rhizome residues obtained by extracting certain enzymes as well as leaves and stems are often discarded as they are, and the use of waste wood is expected by using the present invention. Is done.
本発明者らは鋭意検討した結果、以下に示すような手段により、上記課題を解決できることを見出し、本発明に到達した。すなわち、本発明は、安全性に優れた抗酸化剤に関する。
1.西洋わさびの抽出物が有効成分として含まれることを特徴とする抗酸化剤。
2.西洋わさびの葉、西洋わさびの茎及び/又は西洋わさびの根茎からなる群より選ばれる1種又は2種以上の混合物から、有効成分を含む抽出物を得ることを特徴とする1の抗酸化剤。
3.西洋わさびが、Cochlearia armoracia L.由来の西洋わさびであることを特徴とする1または2の抗酸化剤。
4.有効成分の作用が、抗酸化作用であることを特徴とする1または2の抗酸化剤。
5.西洋わさびの抽出物にポリフェノールが含まれることを特徴とする1または2の抗酸化剤。
6.西洋わさびの抽出物に加えて、さらに、アスコルビン酸及び/又はアスコルビン酸誘導体、並びに/もしくは、アルブチン及び/又はアルブチン誘導体が含まれることを特徴とする1または2の抗酸化剤。
7.西洋わさび抽出物を有効成分として含有することを特徴とする抗酸化剤。
8.西洋わさび抽出物が、西洋わさびの葉の抽出物、西洋わさびの茎の抽出物及び/又は、西洋わさびの根茎の抽出物からなる群より選ばれる1種又は2種以上の混合物であることを特徴とする7の抗酸化剤。
9.西洋わさびが、Cochlearia armoracia L.由来の西洋わさびであることを特徴とする7または8の抗酸化剤。
10.さらに、アスコルビン酸及び/又はアスコルビン酸誘導体、並びに/もしくは、アルブチン及び/又はアルブチン誘導体を含有することを特徴とする7〜9のいずれかの抗酸化剤。
As a result of intensive studies, the present inventors have found that the above problems can be solved by the following means, and have reached the present invention. That is, the present invention relates to an antioxidant excellent in safety.
1. An antioxidant comprising a horseradish extract as an active ingredient.
2. 1. An antioxidant comprising obtaining an extract containing an active ingredient from one or a mixture of two or more selected from the group consisting of horseradish leaf, horseradish stem and / or horseradish rhizome .
3. One or two antioxidants characterized in that the horseradish is horseradish derived from Cochlearia armoracia L.
4). One or two antioxidants, wherein the action of the active ingredient is an antioxidant action.
5. One or two antioxidants characterized in that polyphenols are contained in the horseradish extract.
6). 1 or 2 antioxidant characterized by including ascorbic acid and / or an ascorbic acid derivative, and / or arbutin and / or an arbutin derivative in addition to the extract of a horseradish.
7). An antioxidant comprising horseradish extract as an active ingredient.
8). The horseradish extract is one or a mixture of two or more selected from the group consisting of horseradish leaf extract, horseradish stem extract and / or horseradish rhizome extract 7 antioxidants characterized.
9. 7 or 8 antioxidant, characterized in that the horseradish is horseradish from Cochlearia armoracia L.
10. Furthermore, ascorbic acid and / or an ascorbic acid derivative, and / or arbutin and / or an arbutin derivative, any one of 7-9 characterized by the above-mentioned.
本発明により、強力なスーパーオキシド消去、ヒドロキシラジカル消去等の活性酸素除去機能、チロシナーゼ阻害作用やメラニン生成抑制作用を有する天然の抽出物を含有する抗酸化剤を、安定的に提供することができる。本発明の抗酸化剤は微量で強い抗酸化効果を有しており、該抗酸化剤を人体やその他飲食物、医薬品、化粧品、美白剤、肥料、飼料や皮膚外用剤等に使用することにより、抗酸化効果、特には製品の保存安定性の向上効果等の優れた酸化防止効果や、各種疾病予防効果や抗老化効果等の優れた生体内抗酸化効果を得ることができる。また、バイオマスを利用することから、バイオマス産業界にも大きく寄与することが期待される。 INDUSTRIAL APPLICABILITY According to the present invention, it is possible to stably provide an antioxidant containing a natural extract having a powerful superoxide scavenging function, an active oxygen scavenging function such as hydroxy radical scavenging, a tyrosinase inhibiting action and a melanin production inhibiting action. . The anti-oxidant of the present invention has a strong anti-oxidation effect in a trace amount. By using the anti-oxidant for the human body, other foods and drinks, pharmaceuticals, cosmetics, whitening agents, fertilizers, feeds, skin external preparations and the like. In addition, it is possible to obtain an excellent antioxidant effect such as an antioxidant effect, in particular, an effect of improving the storage stability of the product, and an excellent in vivo antioxidant effect such as various disease preventing effects and anti-aging effects. In addition, the use of biomass is expected to make a significant contribution to the biomass industry.
本発明者らは、前記課題を達成するため鋭意検討した結果、西洋わさびから得られる抽出物が、抗酸化効果、特には製品の保存安定性向上効果等の優れた酸化防止効果と、各種疾病予防効果と、抗老化効果や美白効果等の優れた生体内抗酸化効果を有することを見いだし、本発明を完成するに至った。すなわち、本発明は、西洋わさびから得られる抽出物を有効成分として含有する抗酸化剤に関する。 As a result of diligent studies to achieve the above-mentioned problems, the extract obtained from horseradish has an antioxidant effect, particularly an excellent antioxidant effect such as an effect of improving the storage stability of the product, and various diseases. It has been found that it has an excellent in vivo antioxidant effect such as a preventive effect and an anti-aging effect and a whitening effect, and the present invention has been completed. That is, the present invention relates to an antioxidant containing an extract obtained from horseradish as an active ingredient.
本発明で用いた西洋わさびは、その根茎を摺りおろして、ローストビーフの薬味として辛味料に使用する用途が知られているが、この西洋わさびの抽出物が抗酸化剤として有効であるということは全く知られていない。 The horseradish used in the present invention is known to be used as a spicy seasoning for roast beef by grinding down its rhizomes, but this horseradish extract is effective as an antioxidant. Not known at all.
西洋わさびからの有効成分の抽出において、植物体全体から抽出操作を行ってもよい。また、植物体を大きく、根茎、茎、葉と分別して抽出操作を行ってもよいし、それぞれを組み合わせて抽出操作を実施してもよい。また、通常西洋わさび根茎からは、ある種の酵素を抽出されることが知られているが、酵素を抽出した後に得られ、廃棄されるところの残渣から抽出してもよい。本発明では、使用わさびの根、茎、葉のうち、特に葉に有効成分があることを見いだしているので、好ましくは葉から抽出操作を行うのがよい。西洋わさびは、その根茎を摺りおろして、ローストビーフの薬味として辛味料に使用する用途が知られているが、葉は捨てられているので、その有効利用が期待されている。西洋わさびの葉を利用することで、西洋わさびの生産者や、バイオマス分野の産業に大きく貢献することが期待できる。 In the extraction of active ingredients from horseradish, extraction may be performed from the whole plant body. In addition, the extraction operation may be performed by dividing the plant body into rhizomes, stems, and leaves, or may be performed in combination with each other. In addition, it is generally known that a certain enzyme is extracted from horseradish rhizome, but it may be extracted from a residue obtained after the enzyme is extracted and discarded. In the present invention, it has been found that among the wasabi roots, stems, and leaves used, especially the leaves have active ingredients, and therefore it is preferable to perform the extraction operation from the leaves. Horseradish is known to be used as a spice for roast beef by grinding its rhizomes, but its leaves are discarded, and its effective use is expected. By using the leaves of horseradish, it can be expected to contribute greatly to producers of horseradish and industries in the biomass field.
西洋わさびの植物体は、生の状態、凍結された状態、凍結乾燥された状態のいずれから抽出操作を行ってもよい。好ましくは、生の状態から抽出作業を行うのがよい。生または凍結された西洋わさびから抽出作業を行う場合には、まず、破砕をしても良い。破砕にはミキサー、ホモジナイザー、乳鉢などを用いて破砕すればよい。凍結乾燥されたものは、凍結乾燥操作後、粉状に破砕しても良い。 The horseradish plant may be extracted from any of a raw state, a frozen state, and a lyophilized state. Preferably, the extraction operation is performed from the raw state. When extracting from raw or frozen horseradish, it may be crushed first. What is necessary is just to crush using a mixer, a homogenizer, a mortar, etc. for crushing. The freeze-dried product may be crushed into a powder after the freeze-drying operation.
破砕された植物体は溶媒を用いて、抽出操作を行う。抽出方法として、室温,冷却又は加熱した状態で含浸させて抽出する方法、水蒸気蒸留などの蒸留法を用いて抽出する方法、圧搾して抽出物を得る圧搾法、超臨界流体又は亜臨界流体を用いて抽出する方法などを用いてもよく、これらの方法を単独で、又は2種以上を組み合わせて抽出を行っても良い。好ましくは、細かく裁断した原料1gに対して、5〜100mlの溶媒を用い、1時間から1か月間、好ましくは1〜5日間、室温或いは加熱下で行うことが望ましい。 The crushed plant body is extracted using a solvent. As extraction methods, a method of extracting by impregnating at room temperature, in a cooled or heated state, a method of extracting using a distillation method such as steam distillation, a pressing method of obtaining an extract by pressing, a supercritical fluid or a subcritical fluid Extraction methods may be used, and these methods may be used alone or in combination of two or more. Preferably, 5 to 100 ml of solvent is used per 1 g of finely cut raw material, and it is desirable to carry out at room temperature or under heating for 1 hour to 1 month, preferably 1 to 5 days.
抽出に用いられる溶媒は、有効成分が効果的に抽出される溶媒であれば特に限定されるものではないが、水または、エタノール等の低級アルコールのように水と混和する有機溶媒、またはそれらの混液、または水と混和しない有機溶媒たとえば酢酸エチル等を用いてもよい。そのほかにも例を挙げるならば、メタノール,イソプロパノール,イソブタノール,n-ヘキサノール,メチルアミルアルコール,2-エチルブタノール,n-オクチルアルコール等の1価アルコール類、グリセリン,エチレングリコール,エチレングリコールモノメチルエーテル,プロピレングリコール,プロピレングリコールモノメチルエーテル,プロピレングリコールモノエチルエーテル,トリエチレングリコール,1,3-ブチレングリコール,へキシレングリコール等の多価アルコール又はその誘導体、アセトン,メチルエチルケトン,メチルイソブチルケトン,メチル-n-プロピルケトン等のケトン類,酢酸イソプロピル等のエステル類、エチルエーテル,イソプロピルエーテル,n-ブチルエーテル等のエーテル類、スクワラン,ワセリン,パラフィンワックス,パラフィン油などの炭化水素類、オリーブ油,小麦胚芽油,米油,ゴマ油,マカダミアンナッツ油,アルモンド油,ヤシ油等の植物油脂、牛脂,豚脂,鯨油等の動物油脂などが例示される。また、リン酸緩衝生理食塩水等の無機塩類を添加した極性溶媒、界面活性剤を添加した溶媒を用いることもでき、特に限定されない。飲食物等への使用、皮膚への塗布を含む人体への使用における安全性等を考えれば、特に、水および/またはアルコールのいずれかにより抽出することが好ましい。
The solvent used for the extraction is not particularly limited as long as the active ingredient can be effectively extracted, but water, an organic solvent miscible with water such as a lower alcohol such as ethanol, or the like thereof. A mixed solution or an organic solvent immiscible with water, such as ethyl acetate, may be used. Other examples include monohydric alcohols such as methanol, isopropanol, isobutanol, n-hexanol, methyl amyl alcohol, 2-ethyl butanol, n-octyl alcohol, glycerin, ethylene glycol, ethylene glycol monomethyl ether, Polypropylene glycol, propylene glycol monomethyl ether, propylene glycol monoethyl ether, triethylene glycol, 1,3-butylene glycol, hexylene glycol and other polyhydric alcohols or derivatives thereof, acetone, methyl ethyl ketone, methyl isobutyl ketone, methyl-n-propyl Ketones such as ketones, esters such as isopropyl acetate, ethers such as ethyl ether, isopropyl ether and n-butyl ether, squalane, petrolatum, para Examples include hydrocarbons such as oil wax, paraffin oil, olive oil, wheat germ oil, rice oil, sesame oil, macadamian nut oil, almond oil, coconut oil and other animal oils such as beef tallow, pork fat, whale oil The Moreover, the polar solvent which added inorganic salts, such as phosphate buffered saline, and the solvent which added surfactant can also be used, It does not specifically limit. Considering safety in use for food and drink, application to the human body including application to the skin, etc., extraction with water and / or alcohol is particularly preferable.
また、段階的に抽出操作を行っても良い。たとえば、エタノール等の低級アルコールのように水と混和する有機溶媒で抽出操作を行い、エバポレーターなどで濃縮し、水と混和しない有機溶媒たとえば酢酸エチル等と水を加え、有機層と水層に分離しても良い。この場合、有機層にも水層にもチロシナーゼ阻害作用、メラニン生成抑制作用、抗酸化作用がある成分が抽出されるので、用途別に利用しても構わない。例えば、水層の成分は、洗顔用途、化粧水用途及び入用剤用途など水と親和性が必要な抗酸化剤が所望される場合に利用が期待でき、また、有機層のものはクリーム及び乳液など油と親和性が必要な抗酸化剤が所望される場合に利用が期待できるが、これらに限定されるものではない。 Moreover, you may perform extraction operation in steps. For example, perform extraction with an organic solvent that is miscible with water, such as lower alcohols such as ethanol, concentrate with an evaporator, etc., add an organic solvent that is immiscible with water, such as ethyl acetate and water, and separate the organic layer from the aqueous layer. You may do it. In this case, components having a tyrosinase inhibitory action, a melanin production inhibitory action, and an antioxidant action are extracted in both the organic layer and the aqueous layer, and may be used for different purposes. For example, the components of the aqueous layer can be expected to be used when an anti-oxidant that has an affinity for water is desired, such as facial cleansing applications, skin lotion applications, and use applications. Although it can be expected to be utilized when an antioxidant such as an emulsion that requires affinity for oil is desired, it is not limited thereto.
このようにして得られた西洋わさびの抽出物は、そのまま用いることもできるが、その効果を失わない範囲で、脱臭や脱色などの精製操作を加えたりして用いてもよい。また、抽出物中の有効成分の濃度を高めるために、所望により、得られた抽出物を更に、濃縮、液液分配、吸着クロマトグラフィー、順相もしくは逆相クロマトグラフィー等の手段に付すことも可能である。これらの抽出物や精製物又は分画物は、これらから溶媒を除去することによって乾固物とすることもでき、さらに、アルコールなどの溶媒に可溶化した形態、或いは乳剤の形態で用いることができる。 The extract of horseradish thus obtained can be used as it is, but may be used after adding purification operations such as deodorization and decolorization within the range not losing the effect. Moreover, in order to increase the concentration of the active ingredient in the extract, the obtained extract may be further subjected to means such as concentration, liquid-liquid distribution, adsorption chromatography, normal phase or reverse phase chromatography, if desired. Is possible. These extracts, purified products or fractions can be made into a dry product by removing the solvent from them, and further used in a form solubilized in a solvent such as alcohol, or in the form of an emulsion. it can.
西洋わさびの抽出物に、他のチロシナーゼ阻害作用、メラニン生成抑制作用及び/又は抗酸化作用などを有する薬剤を併用しても構わない。他の薬剤と併用することで相乗効果が期待できる。併用する場合は、安全性の高い薬剤を併用するのが好ましい。より好ましくは、天然由来の薬剤または天然由来の薬剤を模倣した薬剤を併用するのが好ましい。例えば、アスコルビン酸などは、天然に存在し食品用途にも利用されているので、比較的併用しやすい。本発明で使用しても差し支えないL−アスコルビン酸及びその塩又はその誘導体としては、例えばL−アスコルビン酸モノステアレート,L−アスコルビン酸モノパルミテート,L−アスコルビン酸モノオレエート等のアスコルビン酸モノアルキル若しくはモノアルケニルエステル類、L−アスコルビン酸モノリン酸エステル,L−アスコルビン酸-2-硫酸エステル等のアスコルビン酸モノエステル誘導体、L−アスコルビン酸ジステアレート,L−アスコルビン酸ジパルミテート,L−アスコルビン酸ジオレエート等のL−アスコルビン酸ジアルキル若しくはジアルケニルエステル誘導体、L−アスコルビン酸トリステアレート,L−アスコルビン酸トリパルミテート,L−アスコルビン酸トリオレエート等のL−アスコルビン酸トリアルキル若しくはトリアルケニルエステル誘導体、
L−アスコルビン酸トリリン酸エステル等のL−アスコルビン酸トリエステル誘導体等を挙げることが出来る。これらのL−アスコルビン酸及びその塩又はその誘導体のうち、特に好ましいものは、L−アスコルビン酸,L−アスコルビン酸リン酸エステル及びこれらの塩である。コケモモ由来のアルブチンも天然するので比較的安全と考えられるので、併用しても差し支えない。アルブチンの構造を模倣したものまたはその誘導体と併用してもよい。
The horseradish extract may be used in combination with other tyrosinase inhibitory action, melanin production inhibitory action and / or antioxidant action. Synergistic effects can be expected when used in combination with other drugs. When used in combination, it is preferable to use a highly safe drug in combination. More preferably, a naturally occurring drug or a drug imitating a naturally derived drug is used in combination. For example, ascorbic acid and the like are naturally present and are also used for food applications, so they are relatively easy to use together. Examples of L-ascorbic acid and salts or derivatives thereof that may be used in the present invention include monoalkyl ascorbates such as L-ascorbic acid monostearate, L-ascorbic acid monopalmitate, and L-ascorbic acid monooleate. Or monoalkenyl esters, ascorbic acid monoester derivatives such as L-ascorbic acid monophosphate, L-ascorbic acid-2-sulfate, L-ascorbic acid distearate, L-ascorbic acid dipalmitate, L-ascorbic acid dioleate L-ascorbic acid trialkyls such as L-ascorbic acid dialkyl or dialkenyl ester derivatives, L-ascorbic acid tristearate, L-ascorbic acid tripalmitate, L-ascorbic acid trioleate Or tri alkenyl ester derivatives,
Examples include L-ascorbic acid triester derivatives such as L-ascorbic acid triphosphate. Of these L-ascorbic acid and salts thereof or derivatives thereof, particularly preferred are L-ascorbic acid, L-ascorbic acid phosphate and salts thereof. Since arbutin derived from bilberry is also natural, it can be used in combination since it is considered relatively safe. You may use together with what imitated the structure of arbutin, or its derivative (s).
本発明における西洋わさび抽出物は、そのまま抗酸化剤として使用することができ、更に通常の化粧料、医薬部外品等に用いられる成分、例えば油性成分、界面活性剤、紫外線吸収剤、低級アルコール、防腐剤、殺菌剤、色剤、粉末、香料、水溶性高分子、緩衝材等をその剤形にあわせ、本発明の効果を損なわない範囲で適宜配合し抗酸化剤とすることも可能である。この場合、当該抽出物は、抗酸化剤の全組成中に、抽出に用いた植物の乾燥固形分として0.0001〜20重量%、特に0.01〜10重量%配合するのが望ましい。 The horseradish extract in the present invention can be used as an antioxidant as it is, and further components used in ordinary cosmetics, quasi drugs, such as oily components, surfactants, ultraviolet absorbers, lower alcohols Antiseptics, bactericides, colorants, powders, fragrances, water-soluble polymers, buffer materials, etc. can be combined with the dosage form as appropriate and blended as appropriate without compromising the effects of the present invention. is there. In this case, the extract is desirably blended in the total composition of the antioxidant in an amount of 0.0001 to 20% by weight, particularly 0.01 to 10% by weight, as the dry solid content of the plant used for extraction.
また、本発明の皮膚外用剤の剤型は任意であり、例えば化粧水などの可溶化系,クリーム,乳液などの乳化系,カラミンローション等の分散系として、提供することもでき、また噴射剤と共に充填したエアゾールの剤型をとってもよい。 The dosage form of the external preparation for skin of the present invention is arbitrary, and can be provided as a solubilizing system such as lotion, an emulsifying system such as cream or emulsion, or a dispersing system such as calamine lotion, or a propellant. It is also possible to take aerosol dosage forms filled together.
また、本発明の抗酸化剤の形態としては、散剤、カプセル剤(硬カプセル剤、軟カプセル剤など)、顆粒剤(コーティングした物、丸剤、トローチ剤、液剤、またはこれらの製剤学的に許容され得る徐放化製剤など)などが挙げられる。 In addition, the form of the antioxidant of the present invention includes powders, capsules (hard capsules, soft capsules, etc.), granules (coated products, pills, troches, liquids, or pharmaceuticals thereof. Acceptable sustained-release preparations, etc.).
これらの製剤は公知の製剤学的製法に準じ、製剤として薬理学的に許容され得る基剤、担体、賦形剤、崩壊剤、滑沢剤、着色剤等と共に用いてもよい These preparations may be used together with pharmacologically acceptable bases, carriers, excipients, disintegrants, lubricants, coloring agents, etc., in accordance with known pharmaceutical manufacturing methods.
これらの製剤に用いる担体や賦形剤としては、例えば乳糖、ブドウ糖、白糖、マンニトール、馬鈴薯デンプン、トウモロコシデンプン、炭酸カルシウム、リン酸カルシウム、硫酸カルシウム、結晶セルロース、カンゾウ末、ゲンチアナ末などが挙げられる。 Examples of carriers and excipients used in these preparations include lactose, glucose, sucrose, mannitol, potato starch, corn starch, calcium carbonate, calcium phosphate, calcium sulfate, crystalline cellulose, licorice powder, and gentian powder.
これらの製剤に用いる結合剤としては、例えばデンプン、トラガントゴム、ゼラチン、シロップ、ポリビニルアルコール、ポリビニルエーテル、ポリビニルピロリドン、ヒドロキシプロピルセルロース、メチルセルロース、エチルセルロース、カルボキシメチルセルロースなどが挙げられる。 Examples of the binder used in these preparations include starch, tragacanth gum, gelatin, syrup, polyvinyl alcohol, polyvinyl ether, polyvinyl pyrrolidone, hydroxypropyl cellulose, methyl cellulose, ethyl cellulose, carboxymethyl cellulose and the like.
これらの製剤に用いる崩壊剤としては例えばデンプン、寒天、ゼラチン末、カルボキシメチルセルロースナトリウム、カルボキシメチルセルロースカルシウム、結晶セルロース、炭酸カルシウム、炭酸水素ナトリウム、アルギン酸ナトリウムなどが挙げられる。 Examples of the disintegrant used in these preparations include starch, agar, gelatin powder, sodium carboxymethylcellulose, calcium carboxymethylcellulose, crystalline cellulose, calcium carbonate, sodium bicarbonate, sodium alginate and the like.
これらの製剤に用いる滑沢剤としては例えばステアリン酸マグネシウム、タルク、水素添加植物油、マクロゴールなどが挙げられる。 Examples of lubricants used in these preparations include magnesium stearate, talc, hydrogenated vegetable oil, macrogol and the like.
これらの製剤に用いる着色剤としては医薬品に添加することが許容されているものを、それぞれ用いることができる。 As the colorant used in these preparations, those allowed to be added to pharmaceuticals can be used.
錠剤、顆粒剤を調製する場合は、必要に応じて、白糖、ゼラチン、ヒドロキシプロピルセルロース、精製セラック、ゼラチン、グリセリン、ソルビトール、エチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ポリビニルピロリドン、フタル酸セルロースアセテート、ヒドロキシプロピルメチルセルロースフタレート、メチルメタクリレート、メタアクリル酸重合体などで被膜しても良いし、2つ以上の層で被膜しても良い。さらにエチルセルロースやゼラチンのような物質のカプセルでも良い。 When preparing tablets and granules, sucrose, gelatin, hydroxypropylcellulose, purified shellac, gelatin, glycerin, sorbitol, ethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, polyvinylpyrrolidone, cellulose phthalate acetate, It may be coated with hydroxypropylmethylcellulose phthalate, methyl methacrylate, methacrylic acid polymer or the like, or may be coated with two or more layers. Furthermore, capsules of substances such as ethyl cellulose and gelatin may be used.
外用剤の形態としては、経皮投与用または口腔内あるいは経鼻などの経粘膜投与用の固体、半固体、半固体状、または液状の製剤が挙げられる。液状製剤としては、例えば製剤学的に許容される乳剤あるいはローション剤などの乳濁剤、外用チンキ剤、経粘膜投与用液剤などが挙げられる。この製剤は通常用いられる希釈剤としては、例えばエタノール、油分、乳化剤などを含む。半固体製剤としては、例えば油性軟膏、親水性軟膏などの軟膏剤が挙げられる。この製剤は通常用いられる基剤あるいは担体として、例えば、水、ワセリン、ポリエチレングリコール、油分、界面活性剤などを含む。半固体あるいは固体製剤としては、例えば硬膏(ゴム膏、プラスターなど)、フィルム剤、テープ剤、あるいはパップ剤などの経皮投与用または経粘膜(口腔内、経鼻)投与用の貼付剤などが挙げられる。この製剤は通常用いられる基剤あるいは担体として、例えば天然ゴム、ブタジエンゴム、SBR、SISなどの合成ゴムなどのゴム系高分子、ゼラチン、カオリン、酸化亜鉛などの泥状化剤、カルボキシメチルセルロースナトリウム、ポリアクリル酸ナトリウムなどの親水性高分子、アクリル樹脂、流動パラフィンなどの粘着付与剤、水、その他の油分、界面活性剤を含む。これらの製剤は、さらに安定化剤、溶解補助剤、経皮吸収促進剤のような補助剤、あるいは芳香剤、防腐剤などの添加剤などを用いても良い。 Examples of the form of the external preparation include solid, semi-solid, semi-solid, or liquid preparations for transdermal administration or transmucosal administration such as buccal or nasal administration. Examples of liquid preparations include emulsions such as pharmaceutically acceptable emulsions or lotions, tinctures for external use, and solutions for transmucosal administration. This preparation contains, for example, ethanol, oil, emulsifier and the like as a commonly used diluent. Examples of semi-solid preparations include ointments such as oily ointments and hydrophilic ointments. This preparation contains, for example, water, petrolatum, polyethylene glycol, an oil component, a surfactant and the like as a commonly used base or carrier. Examples of semi-solid or solid preparations include patches for transdermal or transmucosal (oral, nasal) administration such as plasters (rubber plaster, plaster, etc.), films, tapes, or poultices. Can be mentioned. This preparation is usually used as a base or carrier, for example, rubber polymers such as natural rubber, butadiene rubber, synthetic rubber such as SBR, SIS, mudizing agents such as gelatin, kaolin, zinc oxide, sodium carboxymethylcellulose, Contains hydrophilic polymer such as sodium polyacrylate, acrylic resin, tackifier such as liquid paraffin, water, other oils, and surfactant. These preparations may further contain additives such as stabilizers, solubilizers, and percutaneous absorption accelerators, or additives such as fragrances and preservatives.
本発明の抗酸化剤は、常法にしたがって経口、非経口の製品に配合することができ、飲食物、皮膚外用剤、医薬品、医薬部外品、飼料、餌料、農薬等の様々な分野で利用することができる。例えば、飲食物に配合した場合には、生体内抗酸化効果および酸化防止効果を有する飲食物を提供することができる。この飲食物は例えば、風味劣化・変色抑制等の酸化防止効果が期待でき、かつ、生活習慣病予防等の効果が期待できる。生活習慣病予防等の効果からは、健康食品、栄養食品等として用いられることも期待できる。さらには、該抽出物の濃縮等の条件を調整することで、これを含有する飲食物を継続的に摂取することにより、更なる効果を発揮する機能的な飲食物を提供することができる。その他、家畜、魚類の飼料、餌料に利用することができ、特に魚類の餌料は水分を必須とするものが多く放置すると酸化劣化し易いものがあり、また、水中投下するので水と接しいたみ易いが、これらを改善した餌料等を提供することができる。また、併せて、一部には飼育の困難な鑑賞用や養殖等の魚類も存在するが、本発明の抗酸化剤を用いた餌料等は生体内抗酸化効果等の効果を有することから、これらの育成・生存率の向上に寄与する餌料等を提供することができる。 The antioxidant of the present invention can be blended into oral and parenteral products according to conventional methods, and is used in various fields such as foods and drinks, external preparations for skin, pharmaceuticals, quasi drugs, feeds, feeds, agricultural chemicals and the like. Can be used. For example, when blended with food and drink, food and drink having an in vivo antioxidant effect and antioxidant effect can be provided. For example, this food and drink can be expected to have an antioxidant effect such as flavor deterioration and discoloration suppression, and can also be expected to have an effect such as prevention of lifestyle-related diseases. From the effect of preventing lifestyle-related diseases, it can be expected to be used as health food, nutritional food, and the like. Furthermore, the functional food and drink which exhibits the further effect can be provided by adjusting the conditions, such as concentration of this extract, by continually ingesting the food and drink containing this. In addition, it can be used for livestock and fish feeds and feeds. Especially, many fish feeds that require water are prone to oxidative degradation, and they can be easily contacted with water because they are dropped in water. However, the feed etc. which improved these can be provided. In addition, some fish for viewing and aquaculture that are difficult to breed also exist in some cases, but the feed using the antioxidant of the present invention has effects such as in vivo antioxidant effect, It is possible to provide foods and the like that contribute to the improvement of these breeding and survival rates.
本発明では、西洋わさび抽出物中に、新鮮重1gの葉から抽出した抽出物中に約0.1〜10mgのポリフェノールが含有されることを見出している。ポリフェノールとは、多くの物質の総称で、これらの中心となるものは、フラボノイドと呼ばれる、化学構造が似ている一連の物質である。フラボノイド系には、フラバノール(カテキン類)、フラボン類、イソフラボン類、フラボノール類、フラバン類、フラバノン類、カルコン類、アントシアニン類などがある。フラボノイド系以外にも、フェニルプロパノイド系、リグナン系、クマリン系、クルクミン類を含むジアリルペプタノイド系、カプサイシン系などがある。そのほかにも多くのポリフェノールがある。 In the present invention, it has been found that about 0.1 to 10 mg of polyphenol is contained in an extract extracted from 1 g of fresh heavy leaves in a horseradish extract. Polyphenol is a general term for many substances, and the center of these is a series of substances called flavonoids with similar chemical structures. Flavonoids include flavanols (catechins), flavones, isoflavones, flavonols, flavans, flavanones, chalcones, anthocyanins. In addition to flavonoids, there are phenylpropanoids, lignans, coumarins, diallylpeptanoids including curcumins, capsaicins, and the like. There are many other polyphenols.
これらのポリフェノールには、抗酸化作用、抗変異原性、抗がん性、血圧上昇抑制作用、血糖抑制作用、抗アレルギー作用、抗菌・抗ウイルス作用などがあることが知られている。特に、ポリフェノールの抗酸化作用は、活性酸素を減らすことで注目されている。これらについては、ポリフェノール全体に共通する構造である複数の水酸基(-OH)が関係していると言われている。この部分が非常に酸化しやすく、共存する他の物質より先にポリフェノールが酸化するため、他の物質の酸化が遅らせるといわれている。またポリフェノールの種類によって反応のしやすさが異なるため、必ずしも1種類のポリフェノールで全ての活性酸素を減らすのは容易ではないことがいわれている。 These polyphenols are known to have antioxidation, antimutagenicity, anticancer, antihypertensive, blood glucose, antiallergic, antibacterial and antiviral effects. In particular, the antioxidant action of polyphenols has attracted attention by reducing active oxygen. These are said to be related to a plurality of hydroxyl groups (—OH), which is a structure common to all polyphenols. It is said that this part is very easy to oxidize, and polyphenols are oxidized before other coexisting substances, so that the oxidation of other substances is delayed. Further, since the ease of reaction varies depending on the type of polyphenol, it is said that it is not always easy to reduce all active oxygen with one type of polyphenol.
本発明では、西洋わさび抽出物にチロシナーゼ阻害作用、メラニン生成抑制作用があることを見出している。これらの作用の一機序として、西洋わさびに含まれるポリフェノールの関与が推測される。メラニン色素は表皮基底層及び毛根部、外毛根鞘に存在する色素細胞(メラノサイト)内の小器官であるメラノソームで生成される。メラニン色素の生成過程は、色素細胞(メラノサイト)内でチロシンにチロシナーゼが活性作用して、チロシンが酸化され、ドーパ、ドーパキノンに変換、更に自動酸化しドーパクロム、5,6-ジヒドロキシインドールを経て重合し、最終的にメラニン色素になる。かくして生成されたメラニンは、色素細胞(メラノサイト)の樹枝状突起から基底細胞に分泌され、基底細胞が分裂し、有棘細胞となると共に上昇し角質層に達する。さらにこのメラニンに紫外線が照射されると、既存のメラニンが酸化され、一時的に黒くなることも報告されている。西洋わさび抽出物にふくまれるポリフェノールが、これらのメラニン色素の生成過程における酸化反応工程を阻害し、チロシナーゼ阻害作用、メラニン生成抑制作用を示すことが推測される。 In the present invention, the horseradish extract has been found to have a tyrosinase inhibitory action and a melanin production inhibitory action. As a mechanism of these actions, the involvement of polyphenols contained in horseradish is presumed. Melanin pigments are produced in melanosomes, which are organelles in pigment cells (melanocytes) present in the basal layer of the epidermis, the hair root, and the outer root sheath. In the process of melanin production, tyrosinase acts on tyrosine in pigment cells (melanocytes), tyrosin is oxidized, converted to dopa and dopaquinone, and further auto-oxidized and polymerized via dopachrome and 5,6-dihydroxyindole. Finally, it becomes a melanin pigment. The melanin thus produced is secreted into the basal cells from the dendrites of the pigment cells (melanocytes), and the basal cells divide and become spiny cells and rise to reach the stratum corneum. Furthermore, it has been reported that when this melanin is irradiated with ultraviolet rays, the existing melanin is oxidized and temporarily becomes black. It is speculated that the polyphenol contained in the horseradish extract inhibits the oxidation reaction step in the production process of these melanin pigments and exhibits a tyrosinase inhibitory action and a melanin production inhibitory action.
以下に実施例を示して本発明を具体的に説明するが、本発明は実施例に限定されるものではない。 EXAMPLES The present invention will be specifically described below with reference to examples, but the present invention is not limited to the examples.
メラニン生成抑制試験方法
メラニン生成抑制試験はマウスのメラノーマ細胞を用いて、次の様に行った。先ず、10%(v/v)牛胎児血清を含むDMEM培地で、5%(v/v)炭酸ガスに調整した炭酸ガスインキュベーターで37℃で1×105個になるよう培養したB16メラノーマ細胞500μlを、24穴細胞培養プレートに播種し、次いでこのプレートに、エタノールに溶解した250mg/ml〜0.025mg/mlの試料を0.5μl添加した。同条件でさらに4日間培養した後その白色化度を顕微鏡下で肉眼で評価し、メラニン生成抑制能の指標とした。
Melanin Production Inhibition Test Method The melanin production inhibition test was performed as follows using mouse melanoma cells. First, B16 melanoma cells cultured in a DMEM medium containing 10% (v / v) fetal bovine serum in a carbon dioxide incubator adjusted to 5% (v / v) carbon dioxide at 37 ° C. to give 1 × 10 5 cells. 500 μl was seeded in a 24-well cell culture plate, and then 0.5 μl of a sample of 250 mg / ml to 0.025 mg / ml dissolved in ethanol was added to the plate. After further culturing for 4 days under the same conditions, the degree of whitening was evaluated with the naked eye under a microscope and used as an index of the ability to suppress melanin production.
チロシナーゼ活性阻害試験方法
Anal.Biochem.,179,375(1989)の方法に従って、被検液750μlにプロリン溶液(80mM、pH7.6リン酸緩衝液に溶解)750μl及びピロカテコール溶液(4mM、pH7.6リン酸緩衝液に溶解)750μlを加え、更に酵素チロシナーゼ溶液(pH6.8リン酸緩衝液に溶解)を終濃度20U/mlになるよう添加し、反応液全量が1mlになるようpH6.8リン酸緩衝液を添加した上で速やかに混合し、直ちに525nmにおける吸光度を測定開始し、反応開始時の測定値(D1)及び反応後10秒時の測定値(D2)を求めた。即ちD1を100%阻害と換算してD2測定時の阻害率を求め(式1)チロシナーゼ活性阻害の指標とした。
Tyrosinase activity inhibition test method
Anal. Biochem., 179, 375 (1989) According to the method of 179,375 (1989), 750 μl of test solution was dissolved in 750 μl of proline solution (dissolved in 80 mM, pH 7.6 phosphate buffer) and pyrocatechol solution (dissolved in 4 mM, pH 7.6 phosphate buffer). ) 750 μl was added, and enzyme tyrosinase solution (dissolved in pH 6.8 phosphate buffer) was added to a final concentration of 20 U / ml, and pH 6.8 phosphate buffer was added so that the total amount of the reaction solution was 1 ml. The mixture was quickly mixed, and the absorbance at 525 nm was immediately started, and the measured value (D 1 ) at the start of the reaction and the measured value (D 2 ) at 10 seconds after the reaction were obtained. That is, D 1 was converted to 100% inhibition, and the inhibition rate at the time of D 2 measurement was obtained (Formula 1), which was used as an index of tyrosinase activity inhibition.
抗酸化作用試験方法
抽出液について、ラジカル消去活性を測定した。すなわち、安定なラジカルであるDPPHを0.5Mになるようエタノールにて調製し、試験管中に0.5ml分注、これに0.1M Tris-HCl(pH7.4)バッファーを0.4ml及びこのバッファーで種々の濃度に調製した抽出物溶解液0.1mlを混合し、常温暗所にて20分反応後517nmにおける吸光度を測定し、この値をAとした。また、強力なラジカルスカベンジャーであるTroloxをエタノールで100mMに調製し、これを抽出物溶解液の代わりに0.1ml添加し同様に反応させた反応液の吸光度を測定し、この値をBとした。さらに、抽出物溶解液の代わりに0.1M Tris-HCl(pH7.4)バッファーを0.1ml添加したブランクの吸光度を測定し、これをCとした。抽出物のラジカル消去率を式2で求めた。
Antioxidant test method Radical scavenging activity was measured for the extract. That is, DPPH which is a stable radical is prepared in ethanol to 0.5M, 0.5 ml is dispensed into a test tube, and 0.4 ml of 0.1M Tris-HCl (pH 7.4) buffer is added to this buffer. The extract solution prepared at a concentration of 0.1 ml was mixed, reacted at room temperature in a dark place for 20 minutes, and then the absorbance at 517 nm was measured. Also, Trolox, which is a powerful radical scavenger, was adjusted to 100 mM with ethanol, 0.1 ml of this was added instead of the extract solution, and the absorbance of the reaction solution reacted in the same manner was measured. Furthermore, the absorbance of a blank to which 0.1 ml of 0.1 M Tris-HCl (pH 7.4) buffer was added instead of the extract solution was measured. The radical scavenging rate of the extract was determined by Equation 2.
ポリフェノール含量の測定方法
ポリフェノール測定装置PA-20(東洋紡エンジニアリング社製)を用いて、抽出物に含まれる総ポリフェノール含量を測定した。方法は、PA-20のマニュアルに従い実施した。検体は50μl使用した。
Measuring method of polyphenol content The total polyphenol content contained in the extract was measured using a polyphenol measuring device PA-20 (manufactured by Toyobo Engineering Co., Ltd.). The method was performed according to the PA-20 manual. 50 μl of sample was used.
西洋わさび(葉及び根茎)抽出物の調製
西洋わさびの葉及び根茎それぞれ100gずつを細かく裁断し、エタノール1000mlを加えて室温下、24時間抽出し抽出液を濾別した。残渣はさらにエタノール200mlを加えて、同様に再抽出した。抽出液を集めて減圧濃縮し、溶媒を留去した後、水20mlおよび酢酸エチル80mlを加え、これを分液ロートに移して激しく振とうした後静置して2層に分離し、上層の酢酸エチル層を集めた。これを無水硫酸ナトリウムで乾燥した後減圧濃縮し、西洋わさび葉抽出物1.367g及び根茎抽出物0.2gを得た。
Preparation of horseradish (leaves and rhizome) extracts 100 g of horseradish leaves and rhizomes were cut into small pieces, added with 1000 ml of ethanol, extracted at room temperature for 24 hours, and the extract was filtered. The residue was further re-extracted in the same manner by adding 200 ml of ethanol. The extract was collected and concentrated under reduced pressure. After distilling off the solvent, 20 ml of water and 80 ml of ethyl acetate were added, and this was transferred to a separatory funnel, shaken vigorously, and allowed to stand to separate into two layers. The ethyl acetate layer was collected. This was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain 1.367 g of horseradish leaf extract and 0.2 g of rhizome extract.
実施例1 メラニン生成抑制試験
前記のメラニン生成抑制試験方法で、西洋わさび葉抽出物について、種々の濃度でメラニン生成抑制を測定した。結果を表1に示す。本発明の抽出物は、終濃度25μg/ml以上の範囲で、実用化に充分な++(白色化度大)のメラニン生成抑制効果を示した。このことは、本発明の抽出物が、優れた抗酸化効果と高い安全性を兼ね備えた、有用な抗酸化成分であることを示すものである。
Example 1 Melanin production inhibition test The melanin production inhibition was measured at various concentrations for the horseradish leaf extract by the melanin production inhibition test method described above. The results are shown in Table 1. The extract of the present invention exhibited a ++ (high whitening degree) melanin production inhibitory effect sufficient for practical use within a final concentration range of 25 μg / ml or more. This indicates that the extract of the present invention is a useful antioxidant component having both an excellent antioxidant effect and high safety.
実施例2 チロシナーゼ活性阻害
西洋わさび葉抽出物及び標準品アルブチン(合成品)について、チロシナーゼ酵素阻害活性を、前記のチロシナーゼ活性阻害試験方法にしたがって調べた。結果を表2に示す。
Example 2 Inhibition of tyrosinase activity The horseradish leaf extract and the standard arbutin (synthetic product) were examined for tyrosinase enzyme inhibition activity according to the tyrosinase activity inhibition test method described above. The results are shown in Table 2.
表2の結果から、アルブチンと天然の西洋わさび葉抽出液からなる本発明の抗酸化剤は、ほぼ同等の濃度でチロシナーゼ酵素活性を抑制した。 From the results shown in Table 2, the antioxidant of the present invention consisting of arbutin and natural horseradish leaf extract inhibited tyrosinase enzyme activity at almost the same concentration.
実施例3 抗酸化作用
西洋わさび葉抽出物について、前記の抗酸化作用試験方法にしたがい、抗酸化試験を実施した。抗酸化試験の結果を図1に示す。葉抽出物は、アルブチンより強い抗酸化作用を示した。根茎抽出物にも、わずかながら抗酸化作用が認められた。
Example 3 Antioxidant action The horseradish leaf extract was subjected to an antioxidant test according to the antioxidant test method described above. The results of the antioxidant test are shown in FIG. The leaf extract showed stronger antioxidant effect than arbutin. A slight antioxidant activity was also observed in the rhizome extract.
実施例4 ポリフェノール含量の測定
ポリフェノール測定装置PA-20(東洋紡エンジニアリング社製)を用いて、抽出物に含ま
れる総ポリフェノール含量を測定したところ、新鮮重1gの葉から抽出した抽出物中に約2mgのポリフェノールが含まれていることが確認された。
Example 4 Measurement of polyphenol content Using polyphenol measuring device PA-20 (manufactured by Toyobo Engineering Co., Ltd.), the total polyphenol content contained in the extract was measured. It was confirmed that about 2 mg of polyphenol was contained therein.
実施例5 クリームの製造
以下に示す組成のクリームを常法により製造した。
得られたクリームは、美白効果に優れたものであり、シミ、ソバカス等の色素沈着症を改善することができた。
Example 5 Production of cream A cream having the following composition was produced by a conventional method.
The obtained cream was excellent in whitening effect and could improve pigmentation diseases such as spots and freckles.
(組成) (重量%)
ステアリン酸 2.5
ステアリルアルコール 6.0
還元ラノリン 2.5
スクワレン 6.0
オクチルデカノール 6.5
ポリエチレンセグリコール 4.0
香料 0.1
防腐剤、酸化防止剤 適量
プロピレングリコール 4.5
西洋わさび抽出液 1.0
精製水 全体で100となる量
(Composition) (wt%)
Stearic acid 2.5
Stearyl alcohol 6.0
Reduced lanolin 2.5
Squalene 6.0
Octyldecanol 6.5
Polyethylene seglycol 4.0
Fragrance 0.1
Preservative, antioxidant Suitable amount Propylene glycol 4.5
Horseradish extract 1.0
Total amount of purified water is 100
実施例6 ローションの製造
以下に示す組成のローションを常法により製造した。
得られたローションは、美白効果に優れたものであり、シミ、ソバカス等の色素沈着症を改善することができた。
Example 6 Production of lotion A lotion having the following composition was produced by a conventional method.
The obtained lotion was excellent in whitening effect, and could improve pigmentation such as spots and freckles.
(組成) (重量%)
ステアリン酸 0.5
セタノール 2.0
ワセリン 2.5
ラノリンアルコール 2.5
流動パラフィン 9.0
ポリエチレンセグリコール 2.5
香料 0.1
グリセリン 3.5
プロピレングリコール 4.5
トリエタノールアミン 1.0
西洋わさび抽出液 2.0
精製水 全体で100となる量
(Composition) (wt%)
Stearic acid 0.5
Cetanol 2.0
Vaseline 2.5
Lanolin alcohol 2.5
Liquid paraffin 9.0
Polyethylene seglycol 2.5
Fragrance 0.1
Glycerin 3.5
Propylene glycol 4.5
Triethanolamine 1.0
Horseradish extract 2.0
Total amount of purified water is 100
本発明により、強力なスーパーオキシド消去、ヒドロキシラジカル消去等の活性酸素除去機能、チロシナーゼ阻害作用やメラニン生成抑制作用を有する天然の抽出物を含有する抗酸化剤を、安定的に提供することができる。本発明の抗酸化剤は微量で強い抗酸化効果を有しており、該抗酸化剤を人体やその他飲食物、医薬品、化粧品、美白剤、肥料、飼料や皮膚外用剤等に使用することにより、抗酸化効果、特には製品の保存安定性の向上効果等の優れた酸化防止効果や、各種疾病予防効果や抗老化効果等の優れた生体内抗酸化効果を得ることができる。従って、産業界に大きく寄与することが期待される。また、バイオマスを利用することから、バイオマス産業界にも大きく寄与することが期待される。 INDUSTRIAL APPLICABILITY According to the present invention, it is possible to stably provide an antioxidant containing a natural extract having a powerful superoxide scavenging function, an active oxygen scavenging function such as hydroxy radical scavenging, a tyrosinase inhibiting action and a melanin production inhibiting action. . The anti-oxidant of the present invention has a strong anti-oxidation effect in a trace amount. By using the anti-oxidant for the human body, other foods and drinks, pharmaceuticals, cosmetics, whitening agents, fertilizers, feeds, skin external preparations and the like. In addition, it is possible to obtain an excellent antioxidant effect such as an antioxidant effect, in particular, an effect of improving the storage stability of the product, and an excellent in vivo antioxidant effect such as various disease preventing effects and anti-aging effects. Therefore, it is expected to greatly contribute to the industry. In addition, the use of biomass is expected to make a significant contribution to the biomass industry.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005268402A JP2006232807A (en) | 2005-01-27 | 2005-09-15 | Antioxidant containing horseradish extract |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005019359 | 2005-01-27 | ||
JP2005268402A JP2006232807A (en) | 2005-01-27 | 2005-09-15 | Antioxidant containing horseradish extract |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2006232807A true JP2006232807A (en) | 2006-09-07 |
Family
ID=37040851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005268402A Pending JP2006232807A (en) | 2005-01-27 | 2005-09-15 | Antioxidant containing horseradish extract |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2006232807A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104068368A (en) * | 2014-06-17 | 2014-10-01 | 浙江严州府食品有限公司 | Color-protecting and crispiness-protecting method of salted radishes |
JP2019031557A (en) * | 2010-09-17 | 2019-02-28 | バレント・バイオサイエンシーズ・リミテッド・ライアビリティ・カンパニーValent BioSciences LLC | Pharmaceutical and nutraceutical compositions of abscisic acid |
WO2019065962A1 (en) * | 2017-09-29 | 2019-04-04 | 株式会社アミノアップ化学 | Caspase 3 activity inhibitor, apoptosis inhibitor, inhibitor of toxicity due to secondary bile acid, and intestinal tract disorder inhibitor |
-
2005
- 2005-09-15 JP JP2005268402A patent/JP2006232807A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019031557A (en) * | 2010-09-17 | 2019-02-28 | バレント・バイオサイエンシーズ・リミテッド・ライアビリティ・カンパニーValent BioSciences LLC | Pharmaceutical and nutraceutical compositions of abscisic acid |
JP2020019782A (en) * | 2010-09-17 | 2020-02-06 | バレント・バイオサイエンシーズ・リミテッド・ライアビリティ・カンパニーValent BioSciences LLC | Pharmaceutical and nutraceutical compositions of abscisic acid |
JP2021075557A (en) * | 2010-09-17 | 2021-05-20 | バレント・バイオサイエンシーズ・リミテッド・ライアビリティ・カンパニーValent BioSciences LLC | Pharmaceutical and nutraceutical compositions of abscisic acid |
JP7217763B2 (en) | 2010-09-17 | 2023-02-03 | バレント・バイオサイエンシーズ・リミテッド・ライアビリティ・カンパニー | Pharmaceutical and nutraceutical abscisic acid compositions |
CN104068368A (en) * | 2014-06-17 | 2014-10-01 | 浙江严州府食品有限公司 | Color-protecting and crispiness-protecting method of salted radishes |
CN104068368B (en) * | 2014-06-17 | 2016-03-23 | 浙江严州府食品有限公司 | A method of preserving color and crispness of pickled radish |
WO2019065962A1 (en) * | 2017-09-29 | 2019-04-04 | 株式会社アミノアップ化学 | Caspase 3 activity inhibitor, apoptosis inhibitor, inhibitor of toxicity due to secondary bile acid, and intestinal tract disorder inhibitor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10323055B2 (en) | Plant extraction method and compositions | |
JP2012502020A (en) | Cosmetic composition comprising polyhydroxylate (POLYHYDROXYLTATE) fatty alcohol and derivatives and uses thereof | |
Nunes et al. | Potential therapeutic of olive oil industry by-products in skin health: A review | |
KR102642352B1 (en) | Bakuchiol compositions for treatment of post inflammatory hyperpigmentation | |
JP4975069B2 (en) | Tyrosinase inhibitor | |
JP5751981B2 (en) | Novel phenylethanoid glycosides and skin cosmetics | |
JP6055667B2 (en) | Collagen production promoter | |
KR101846032B1 (en) | Cosmetic composition of deodorant comprising essential oil from plant and polyphenol compound | |
JP2004075619A (en) | Type 2 helper t cell type cytokinin inhibitor | |
WO2016110276A1 (en) | Topical composition containing obakunone and skin-whitening method using same | |
KR20140012456A (en) | Composition for improving skin conditions comprising akebia saponin d | |
KR101863297B1 (en) | Composition for preventing or improving skin wrinkle comprising chlorogenic acid and rutin compound as active ingredient | |
CA2606392A1 (en) | Hair tonic | |
JPH05163135A (en) | Beautifying cosmetic composition | |
WO2018146066A1 (en) | Marsdenia cundurango creeper extracts, cosmetic compositions comprising them and cosmetic uses of same | |
KR100836941B1 (en) | Antioxidant Compound Isolated from Chaga and Composition Comprising the Same | |
JP2006232807A (en) | Antioxidant containing horseradish extract | |
JP2012051837A (en) | Glutathione production promoter | |
JP2010018545A (en) | Active oxygen scavenger, and skin care preparation for external use, composition for oral cavity and food | |
KR100742267B1 (en) | Seojangchae chrysanthemum extract, preparation method thereof and whitening cosmetic composition containing same as active ingredient | |
WO2011038472A1 (en) | Standardized plant extract, method for preparing an extract from plants of the sclerolobium genus, cosmetic composition, pharmaceutical composition and use of said extract | |
KR102244585B1 (en) | Complex cosmetic composition for improving skin-aging | |
JP2008303180A (en) | Skin-lightening agent, skincare preparation for external use, and functional oral composition | |
KR101434163B1 (en) | A pharmaceutical with anti oxidant, anti inflammatory and skin whitening effect comprising the extract from aerial part of pueraria thunbergiana | |
KR100930592B1 (en) | Skin whitening and antioxidant composition containing extracts against |